Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Alignment of practice guidelines with targeted-therapy drug funding policies in Ontario.

Ramjeesingh R, Meyer RM, Brouwers M, Chen BE, Booth CM.

Curr Oncol. 2013 Feb;20(1):e21-33. doi: 10.3747/co.20.1166.

2.

Clinical guidelines and payer policies on fusion for the treatment of chronic low back pain.

Cheng JS, Lee MJ, Massicotte E, Ashman B, Gruenberg M, Pilcher LE, Skelly AC.

Spine (Phila Pa 1976). 2011 Oct 1;36(21 Suppl):S144-63. doi: 10.1097/BRS.0b013e31822ef5b4. Review.

PMID:
21952186
3.
4.

Practitioners as experts: the influence of practicing oncologists "in-the-field" on evidence-based guideline development.

Browman GP, Makarski J, Robinson P, Brouwers M.

J Clin Oncol. 2005 Jan 1;23(1):113-9.

PMID:
15625366
5.

Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases - an evidence-based practice guideline.

Wu JS, Wong RK, Lloyd NS, Johnston M, Bezjak A, Whelan T; Supportive Care Guidelines Group of Cancer Care Ontario.

BMC Cancer. 2004 Oct 4;4:71.

6.

Heat or eat: the Low Income Home Energy Assistance Program and nutritional and health risks among children less than 3 years of age.

Frank DA, Neault NB, Skalicky A, Cook JT, Wilson JD, Levenson S, Meyers AF, Heeren T, Cutts DB, Casey PH, Black MM, Berkowitz C.

Pediatrics. 2006 Nov;118(5):e1293-302.

PMID:
17079530
7.

Evidence based evaluation of immuno-coagulatory interventions in critical care.

Afshari A.

Dan Med Bull. 2011 Sep;58(9):B4316. Review.

PMID:
21893014
8.

The process of developing best practice guidelines for nurses in Ontario: risk assessment and prevention of pressure ulcers.

MacLeod FE, Harrison MB, Graham ID.

Ostomy Wound Manage. 2002 Oct;48(10):30-2, 34-8.

PMID:
12378001
9.

Ontario doctors' attitudes toward and use of clinical practice guidelines in oncology.

Graham ID, Brouwers M, Davies C, Tetroe J.

J Eval Clin Pract. 2007 Aug;13(4):607-15.

PMID:
17683303
10.

Quality and consistency of guidelines for the management of mild traumatic brain injury in the emergency department.

Tavender EJ, Bosch M, Green S, O'Connor D, Pitt V, Phillips K, Bragge P, Gruen RL.

Acad Emerg Med. 2011 Aug;18(8):880-9. doi: 10.1111/j.1553-2712.2011.01134.x.

11.
12.

Reported use of intravesical therapy for non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Advocacy Network (BCAN) survey.

Nielsen ME, Smith AB, Pruthi RS, Guzzo TJ, Amiel G, Shore N, Lotan Y.

BJU Int. 2012 Oct;110(7):967-72. doi: 10.1111/j.1464-410X.2012.11060.x. Epub 2012 Apr 4.

13.

Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline.

Wong RK, Berry S, Spithoff K, Simunovic M, Chan K, Agboola O, Dingle B; Gastrointestinal Cancer Disease Site Group.

Clin Oncol (R Coll Radiol). 2010 May;22(4):265-71. doi: 10.1016/j.clon.2010.03.002.

PMID:
20398849
14.

Association of unstable angina guideline care with improved survival.

Giugliano RP, Lloyd-Jones DM, Camargo CA Jr, Makary MA, O'Donnell CJ.

Arch Intern Med. 2000 Jun 26;160(12):1775-80.

PMID:
10871970
15.

Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.

Bhandari M, Busse JW, Jackowski D, Montori VM, Sch√ľnemann H, Sprague S, Mears D, Schemitsch EH, Heels-Ansdell D, Devereaux PJ.

CMAJ. 2004 Feb 17;170(4):477-80.

16.

Clinical practice guideline on the optimal radiotherapeutic management of brain metastases.

Tsao MN, Lloyd NS, Wong RK; Supportive Care Guidelines Group of Cancer Care Ontario's Program in Evidence-based Care.

BMC Cancer. 2005 Apr 4;5:34.

17.

Funding new cancer drugs in Ontario: closing the loop in the practice guidelines development cycle.

Pater JL, Browman GP, Brouwers MC, Nefsky MF, Evans WK, Cowan DH.

J Clin Oncol. 2001 Jul 15;19(14):3392-6.

PMID:
11454887
18.
19.

Using Data From Ontario's Episode-Based Funding Model to Assess Quality of Chemotherapy.

Kaizer L, Simanovski V, Lalonde C, Tariq H, Blais I, Evans WK.

J Oncol Pract. 2016 Oct;12(10):e870-e877.

PMID:
27858565
20.

Clinician participation in CADTH's pan-Canadian Oncology Drug Review: contribution and impact on cancer drug funding recommendations.

Trudeau M, Hoskins P, Reiman T, Chambers A, Mai H, Wheatley-Price P.

Curr Oncol. 2017 Apr;24(2):71-74. doi: 10.3747/co.24.3644. Epub 2017 Apr 27. No abstract available.

Supplemental Content

Support Center